Canagliflozin: What It Is, How It Works, and What You Need to Know

When you're managing canagliflozin, a type of SGLT2 inhibitor used to treat type 2 diabetes by helping the kidneys remove excess sugar through urine. Also known as Invokana, it's one of the most prescribed diabetes medications in Canada because it doesn't just lower blood sugar—it also helps with weight and blood pressure. Unlike older drugs that force your body to make more insulin, canagliflozin lets your body do the work naturally. It blocks a protein in your kidneys called SGLT2, which normally reabsorbs sugar back into your bloodstream. When that block happens, sugar flows out with your urine instead of staying in your system. That’s why people on canagliflozin often lose a few pounds without trying.

It’s not just about sugar. Studies show canagliflozin reduces the risk of heart failure and kidney damage in people with type 2 diabetes, especially those already at risk. That’s why doctors now recommend it not just for blood sugar control, but for long-term protection. It works well with metformin, and even on its own if other drugs haven’t helped. But it’s not for everyone. If you have kidney problems, low blood pressure, or get frequent urinary infections, you’ll need to talk to your doctor before starting. And because it increases urination, staying hydrated is non-negotiable.

Canagliflozin is part of a bigger shift in how we treat diabetes—not just chasing numbers, but protecting your heart, kidneys, and overall health. It’s one of several SGLT2 inhibitors, a class of diabetes drugs that work by making the kidneys flush out sugar, including dapagliflozin and empagliflozin. Each has slight differences in how they’re dosed or how they affect the body, but they all share the same core mechanism. And because they’re often used alongside other medications like metformin, the first-line drug for type 2 diabetes that reduces liver sugar production and improves insulin sensitivity, understanding how they interact matters. You might be on a combo pill, or your doctor might switch you from an older drug to canagliflozin because your current treatment isn’t giving you the full benefits.

What you won’t find in most patient brochures is how real people manage the side effects—like the increased risk of yeast infections or the need to adjust your fluid intake. That’s why the posts below cover practical details you won’t get from a pharmacy label: how to spot early signs of trouble, what to do if your blood sugar drops too low when combined with other meds, and how canagliflozin compares to alternatives in cost, effectiveness, and daily life impact. Whether you’re just starting out or switching meds, these real-world insights help you make smarter choices without guessing.

SGLT2 Inhibitors and Bone Health: What You Need to Know About Fracture Risk

SGLT2 Inhibitors and Bone Health: What You Need to Know About Fracture Risk

SGLT2 inhibitors help manage diabetes and protect the heart and kidneys, but canagliflozin may increase fracture risk in vulnerable patients. Empagliflozin and dapagliflozin appear safe for bone health.

Read more